Lynn C. Moscinski

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro et al. · Immunity · 1999 · 1.6K citations · Full text

Cell Regulation, Constitutive Activation, Medicine +8

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

Jianjun Zhao, Jianhong Lin, Tint Lwin et al. · Blood · 2010 · 334 citations

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3

Prince George, Purva Bali, Srinivas Annavarapu et al. · Blood · 2004 · 322 citations

Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.

Ramadevi Nimmanapalli, Lianne Fuino, Purva Bali et al. · PubMed · 2003 · 280 citations

Histone Modifications, Mixed-phenotype Acute Leukemia, Cell Death +18

Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma

Xiangning Wang, Richard Heller, Nancy VanVoorhis et al. · Annals of Surgery · 1994 · 276 citations